PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1887

  1. 55 Posts.
    lightbulb Created with Sketch. 9
    The doctor in this video seems to be already doing everything for knee arthritis that we are hoping to achieve. If we have an excusive deal with BenePharma for the supply of FDA approved iPPS , where is he getting his supply from. How do we protect our hoped for monopoly for the use of iPPS for KOA
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.